These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Newborn Screening for Cystic Fibrosis in California. Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L; Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590 [TBL] [Abstract][Full Text] [Related]
26. Neonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity. Spence WC; Paulus-Thomas J; Orenstein DM; Naylor EW Biochem Med Metab Biol; 1993 Apr; 49(2):200-11. PubMed ID: 7683477 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis. Scotet V; De Braekeleer M; Audrézet MP; Lodé L; Verlingue C; Quéré I; Mercier B; Duguépéroux I; Codet JP; Moineau MP; Parent P; Férec C Clin Genet; 2001 Jan; 59(1):42-7. PubMed ID: 11168024 [TBL] [Abstract][Full Text] [Related]
28. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations. Padoan R; Bassotti A; Seia M; Corbetta C Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388 [TBL] [Abstract][Full Text] [Related]
29. Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis. Padoan R; Genoni S; Moretti E; Seia M; Giunta A; Corbetta C Acta Paediatr; 2002; 91(1):82-7. PubMed ID: 11883825 [TBL] [Abstract][Full Text] [Related]
30. [Neonatal screening for cystic fibrosis]. Tellería Orriols JJ; Alonso Ramos MJ; Garrote Adrados JA; Fernández Carvajal I; Blanco Quirós A An Esp Pediatr; 2002 Jul; 57(1):60-5. PubMed ID: 12139895 [TBL] [Abstract][Full Text] [Related]
31. Screening for cystic fibrosis in New York State: considerations for algorithm improvements. Kay DM; Maloney B; Hamel R; Pearce M; DeMartino L; McMahon R; McGrath E; Krein L; Vogel B; Saavedra-Matiz CA; Caggana M; Tavakoli NP Eur J Pediatr; 2016 Feb; 175(2):181-93. PubMed ID: 26293390 [TBL] [Abstract][Full Text] [Related]
32. Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden. Schaedel C; Hjelte L; de Monestrol I; Johannesson M; Kollberg H; Kornfält R; Holmberg L Clin Genet; 1999 Oct; 56(4):318-22. PubMed ID: 10636451 [TBL] [Abstract][Full Text] [Related]
33. Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA. Krulišová V; Balaščaková M; Skalická V; Piskáčková T; Holubová A; Paděrová J; Křenková P; Dvořáková L; Zemková D; Kračmar P; Chovancová B; Vávrová V; Stambergová A; Votava F; Macek M Eur J Pediatr; 2012 Aug; 171(8):1223-9. PubMed ID: 22581207 [TBL] [Abstract][Full Text] [Related]
34. The impact of newborn screening on cystic fibrosis testing in Victoria, Australia. Balnaves ME; Bonacquisto L; Francis I; Glazner J; Forrest S J Med Genet; 1995 Jul; 32(7):537-42. PubMed ID: 7562966 [TBL] [Abstract][Full Text] [Related]
35. Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening. Kay DM; Langfelder-Schwind E; DeCelie-Germana J; Sharp JK; Maloney B; Tavakoli NP; Saavedra-Matiz CA; Krein LM; Caggana M; Kier C; Pediatr Pulmonol; 2015 Aug; 50(8):771-80. PubMed ID: 26098992 [TBL] [Abstract][Full Text] [Related]
36. A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium. Schmidt M; Werbrouck A; Verhaeghe N; De Wachter E; Simoens S; Annemans L; Putman K Acta Clin Belg; 2020 Jun; 75(3):212-220. PubMed ID: 31007159 [No Abstract] [Full Text] [Related]
37. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening. Sontag MK; Corey M; Hokanson JE; Marshall JA; Sommer SS; Zerbe GO; Accurso FJ J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337 [TBL] [Abstract][Full Text] [Related]
38. False-positive results in neonatal screening for cystic fibrosis based on a three-stage protocol (IRT/DNA/IRT): Should we adjust IRT cut-off to ethnic origin? Cheillan D; Vercherat M; Chevalier-Porst F; Charcosset M; Rolland MO; Dorche C J Inherit Metab Dis; 2005; 28(6):813-8. PubMed ID: 16435172 [TBL] [Abstract][Full Text] [Related]
39. Secondhand Smoke Exposure and Serum Trypsinogen in Cystic Fibrosis Carriers. Ellery KM; Kopp B; Conwell DL; Gariepy C Pancreas; 2019 Oct; 48(9):1155-1159. PubMed ID: 31593019 [TBL] [Abstract][Full Text] [Related]